Introduction
A fusion protein of the constitutively dimeric 26 kDa glutathione S-transferase from Schistosoma japonicum (SjGST) with the fulllength intracellular domain of the human insulin receptor facilitates investigation of receptor tyrosine kinase activation mediated by dimerization (Baer et al., 2001) . As the structures of both the core kinase domain of the human insulin receptor (IRK; Hubbard et al., 1994) and SjGST (McTigue et al., 1995) are known, we attempted to crystallize the corresponding fusion protein, SjGST-IRK, by means of carrier-protein-driven crystallization Lim et al., 1994; Zhan et al., 2001; Smyth et al., 2003) . The construct SjGST-IRK was shown to be stable during purification and kinase activity was demonstrated in both auto-and substrate-phosphorylation assays (Baer, personal communication) .
Crystallization experiments with the fusion protein yielded crystals that were shown to consist of SjGST only. The fusion protein is obviously cleaved under the crystallization conditions and the released SjGST crystallizes in a new crystal form (P2 1 2 1 2 1 ), showing distinctively novel features of the dimer interface and ligand-binding site. Coordinates and structure factors have been deposited in the PDB (PDB code 1y6e).
Experimental methods
Cloning of the construct GST-IRK will be described elsewhere (Baer et al., manuscript in preparation) . A PCR product comprising the coding region of IRK (residues Val966-Lys1271, C969S, Y972F) was cloned into pAc-G2T, resulting in a fusion protein containing a thrombin-cleavage site as a linker between GST and IRK. Expression in Sf9 cells and purification was performed according to Baer et al. (2001) , with the exception that the crude lysate was incubated for 30 min at 277 K after adding Triton X-100 in order to solubilize SjGST-IRK and Tris-(2-carboxyethyl)-phosphine hydrochloride (TCEP) was used as a reducing agent during purification and subsequent crystallization. 10 9 cells from a 1 l fermentation typically yielded 10 mg of GST-IRK, which was found to be electrophoretically pure ( Fig. 1) .
Prior to crystallization, GST-IRK was concentrated to 10 mg ml À1 in 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM TCEP in a 30 kDa concentrator (Amicon, Millipore). Crystallization trials were set up directly after purification at 294 K with the modified microbatch method (D'Arcy et al., 2003) and crystals appeared within 7 d with 0.1 M Bis-Tris pH 5.5, 25%(w/v) PEG 3350 (Index Screen condition No. 42; Hampton Research) and 0.1 M sodium acetate pH 5.5, 36%(w/v) PEG MME 5000 (Stura Footprint Screen 2 condition No. 20; Molecular Dimensions Ltd) as precipitant solutions. Crystals grew to a maximum diameter of 15 mm within 7 d and were flash-frozen in liquid nitrogen directly from the screening plates.
Data were collected at the Swiss Light Source beamline X06SA at 100 K using a 165 mm MAR CCD detector with a 260 mm crystal-todetector distance and an oscillation range of 1 . 180 frames were collected and processed with DENZO and SCALEPACK (Otwinowski, 1993). Despite their small size, the crystals diffracted to 3.0 Å resolution and analysis of the systematic abscences revealed that they belong to space group P2 1 2 1 2 1 . A noncrystallographic twofold axis generates one GST dimer per asymmetric unit. The crystallographic parameters are summarized in Table 1. A molecular-replacement solution was found with the program MOLREP (Vagin & Teplyakov, 1997; Collaborative Computational Project, Number 4, 1994) using the modified PDB entry 1dug (Ware et al., 1999) , i.e. an unligated dimer of GST comprising residues 1-217. Following rigid-body refinement in REFMAC (Murshudov et al., 1997; Collaborative Computational Project, Number 4, 1994) , the structure of orthorhombic GST was refined by iterative conjugategradient minimization with subsequent grouped B-factor refinement in CNX (Brü nger, 1992) and manual model building with MOLOC (Gerber, 1992 ; refinement statistics in Table 1 ). The two carboxy-terminal amino acids Pro217 and Lys218 have been omitted from refinement because no clear electron density was visible for these residues. Based on the same argument, six residues (i.e. SDLVPR) of the linker peptide encoded by pAc-G2T that were still attached at the carboxy-terminus of the SjGST moiety according to mass spectrometry and amino-terminal sequencing (data not shown) were also left out from refinement. Finally, 16 water molecules were added manually based on electron density and hydrogen bonding.
Results and discussion
Analysis of the X-ray data resulted in determination of the space group as orthorhombic P2 1 2 1 2 1 , with unit-cell parameters a = 161.22, b = 50.75, c = 57.50 Å . The calculated volume of the asymmetric unit, 117 622.3 Å 3 , was obviously incompatible with the presence of the intact fusion protein with a molecular weight of 61 kDa. Consequently, we concluded that only a fragment of SjGST-IRK had crystallized. Although the fusion protein had been purified to homogeneity, it was realised that the protein spontaneously degraded to SjGST and IRK during prolonged storage on ice (i.e. within 10 d), independent of the purification protocol employed (Fig. 1) . Addition of protease inhibitors (RoComplete, Roche; diisopropyl fluorophosphate, Fluka) to the storage buffer did not prevent degradation and no proteases could be detected using a sensitive spectroscopic assay with resorufin-labelled casein as substrate (Universal Protease Substrate assay, Roche). We assume that spontaneous autocatalytic cleavage as described for nucleolin (Chen et al., 1991) , which also undergoes degradation independent of both exogenous and endogenous protease activity, could be the reason for the degradation. Replacement of the pAc-G2T linker with a thrombin-cleavage site by a more rigid connection according to Smyth et al. (2003) was not pursued as the introduction of a (Gly-Ala) 5 linker resulted in significant loss of activity in autophosphorylation assays indicating suboptimal alignment of the kinase domains.
Molecular-replacement trials with a high-resolution structure of SjGST (PDB code 1dug) were performed which yielded marked peaks for both the rotation and translation functions. Given the crystal packing and electron density, the crystals were determined to consist of SjGST crystallized in space group P2 1 2 1 2 1 (Table 1) . To our knowledge these are the first orthorhombic crystals of SjGST, as exclusively tetragonal and hexagonal crystal forms have been reported so far (Table 2 ; for a review, see Zhan et al., 2001) . For the deposited SjGST structures no correlation exists between space group and crystallization conditions in terms of protein fusion or presence of ligand ( Table 2) . Inspection of the crystal packing in orthorhombic SjGST leads to the conclusion that the solvent-channel cavity around the carboxy-termini could potentially accommodate covalently linked peptides but no larger protein domain for carrier- 
Figure 1
SDS-PAGE. Lane 1 shows the pooled elution fractions of SjGST-IRK from a gelfiltration column. In lane 2 the same preparation is depicted after storage on ice for 10 d. The molecular weights (kDa) of the marker proteins are indicated. The F o À F c simulated-annealing omit electron-density map contoured at 4 clearly indicates that the side chains of Tyr103 are rotated by approximately 100 around the C -C bond and the positions of the side chains of Arg107 are considerably different compared with all previously published SjGST structures (Fig. 2) . The phenyl hydroxy group of Tyr103 in chain A is at a hydrogen-bonding distance from the guanidinium group of Arg107 of chain B (and vice versa), thereby establishing a reciprocal dimer contact. Interestingly, residue Tyr103 of SjGST is a critical part of the hydrophobic binding site (H-site) for endogenous substrates, xenobiotics and the only effective anti-schistosomial drug praziquantel, which additionally contacts Arg107 (McTigue et al., 1995; Cardoso et al., 2003; Hu et al., 2004) . In the structure presented here, Tyr103 partially occupies the praziquantel-binding site. Although the structure of SjGST with bound praziquantel and its corresponding apo-structure (PDB codes 1gtb and 1gta, respectively; McTigue et al., 1995) imply a preformed binding site for the drug, our data reveal a conformational flexibility for the critical residues Tyr103 and Arg107. This, together with the absence of a homologous tyrosine residue in mammalian GSTs (McTigue et al., 1995) , might support the design of specific drugs targeting the 26 kDa GST of Schistosoma spp., which have already been shown to develop resistance against praziquantel (Hu et al., 2004 , and references therein). The need for novel highly potent drugs is also emphasized by the finding that an estimated 250 million people are infected with Schistosoma spp.
